IL17A and myeloid sarcoma: In humans, MS patients show increased IL17 levels (34), infiltration of CD3+IL17+ cells within MS brain lesions (35), and a significantly higher percentage of peripheral blood CD3+CD8+CD161high cells compared to healthy subjects (15).